IN2014DN08398A - - Google Patents
Info
- Publication number
- IN2014DN08398A IN2014DN08398A IN8398DEN2014A IN2014DN08398A IN 2014DN08398 A IN2014DN08398 A IN 2014DN08398A IN 8398DEN2014 A IN8398DEN2014 A IN 8398DEN2014A IN 2014DN08398 A IN2014DN08398 A IN 2014DN08398A
- Authority
- IN
- India
- Prior art keywords
- biomarker
- parkinson
- disease
- drug
- relates
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2835—Movement disorders, e.g. Parkinson, Huntington, Tourette
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB201206382A GB201206382D0 (en) | 2012-04-11 | 2012-04-11 | Parkinson's disease biomarker |
PCT/GB2013/050926 WO2013153386A1 (en) | 2012-04-11 | 2013-04-10 | Parkinson's disease biomarker |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN08398A true IN2014DN08398A (enrdf_load_stackoverflow) | 2015-05-08 |
Family
ID=46177150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN8398DEN2014 IN2014DN08398A (enrdf_load_stackoverflow) | 2012-04-11 | 2013-04-10 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150104806A1 (enrdf_load_stackoverflow) |
EP (1) | EP2836842A1 (enrdf_load_stackoverflow) |
GB (1) | GB201206382D0 (enrdf_load_stackoverflow) |
IN (1) | IN2014DN08398A (enrdf_load_stackoverflow) |
WO (1) | WO2013153386A1 (enrdf_load_stackoverflow) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5997394B2 (ja) * | 2014-02-18 | 2016-09-28 | 公益財団法人東京都医学総合研究所 | パーキンソン病のバイオマーカーおよびその利用 |
EP3288963B1 (en) * | 2015-05-01 | 2020-12-23 | Wo, Andrew Man Chung | Pink1 c-terminal domain polypeptide and methods using the same in cancer treatment |
GB201516342D0 (en) * | 2015-09-15 | 2015-10-28 | Univ Dundee | Downstream targets of PINK1 |
US11360102B2 (en) | 2015-09-23 | 2022-06-14 | Boston Medical Center Corporation | Biomarkers for the early detection of Parkinson's disease |
EP3661413A1 (en) * | 2017-08-01 | 2020-06-10 | Cove Bio LLC | Biomarkers associated with parkinson's disease |
US12259355B2 (en) | 2018-03-19 | 2025-03-25 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
US12253490B2 (en) | 2018-03-19 | 2025-03-18 | Regeneron Pharmaceuticals, Inc. | Microchip capillary electrophoresis assays and reagents |
CN113227788B (zh) * | 2019-03-19 | 2023-11-21 | 中南大学湘雅医院 | 一种辅助诊断和治疗帕金森病的方法和试剂 |
WO2024081653A2 (en) * | 2022-10-12 | 2024-04-18 | Acurex Biosciences Corporation | Methods of lowering miro2 to treat neurodegenerative diseases |
-
2012
- 2012-04-11 GB GB201206382A patent/GB201206382D0/en not_active Ceased
-
2013
- 2013-04-10 EP EP13718358.8A patent/EP2836842A1/en not_active Withdrawn
- 2013-04-10 WO PCT/GB2013/050926 patent/WO2013153386A1/en active Application Filing
- 2013-04-10 US US14/391,372 patent/US20150104806A1/en not_active Abandoned
- 2013-04-10 IN IN8398DEN2014 patent/IN2014DN08398A/en unknown
Also Published As
Publication number | Publication date |
---|---|
GB201206382D0 (en) | 2012-05-23 |
EP2836842A1 (en) | 2015-02-18 |
US20150104806A1 (en) | 2015-04-16 |
WO2013153386A1 (en) | 2013-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014DN08398A (enrdf_load_stackoverflow) | ||
WO2013066764A3 (en) | Alzheimer's disease signature markers and methods of use | |
MX2016002423A (es) | Composiciones y metodos de diagnostico para el tratamiento de glioblastoma. | |
EP4356960A3 (en) | Biomarkers and methods of treating pd-1 and pd-l1 related conditions | |
WO2015094995A3 (en) | Gene signature biomarkers of tumor response to pd-1 antagonists | |
IL246917B (en) | Biomarker and early diagnosis methods for Alzheimer's disease | |
WO2014140254A9 (en) | Improved user interface for acquistion, display and analysis of ophthalmic diagnostic data | |
WO2013192274A3 (en) | Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy | |
EP3060913A4 (en) | Biomarkers and diagnostic methods for alzheimer's disease and other neurodegenerative disorders | |
MX358474B (es) | Biomarcadores salivales específicos para detección de riesgo, diagnóstico temprano, pronóstico y vigilancia de las enfermedades de alzheimer y de parkinson. | |
BR112013022493A2 (pt) | equipamento e método para examinar, diagnosticar ou auxiliar no diagnóstico e no tratamento de problemas funcionais de visão | |
HUE045724T2 (hu) | GRPR antagonisták GRPR-pozitív rák kimutatására, diagnózisára és kezelésére | |
HK1204544A1 (en) | Methods and assessment scales for measuring wrinkle severity | |
BR112014014960A2 (pt) | métodos para o diagnóstico da doença de alzheimer | |
NZ716643A (en) | Methods for predicting the risk of having a cardiovascular event and for monitoring the treatment of a cardiovascular event | |
HK1197085A1 (en) | Genetic variants for predicting risk of breast cancer | |
WO2015013508A3 (en) | Methods for diagnosing and treating immune disease | |
IN2014DN08537A (enrdf_load_stackoverflow) | ||
MX2017001293A (es) | Metodos y composiciones para diagnosticar y tratar trastornos inflamatorios del intestino. | |
WO2014052685A3 (en) | Devices and methods for single cell analysis | |
HK1232289A1 (zh) | 分拣蛋白作为针对情感/心境障碍的生物标记的用途 | |
NZ729773A (en) | Biomarkers for disease progression in melanoma | |
PH12017502099B1 (en) | Methods for diagnosing and assessing treatment for cushing's syndrome | |
WO2015069883A3 (en) | Oxidized fraction of extracellular dna as a biomarker of stress and methods for using the same | |
EP2983693A4 (en) | SEPT4 / ARTS AS TUMOR SUPPRESSOR IN THE DIAGNOSIS, FORECASTING AND TREATMENT OF LIVER DISEASES |